Barbara Richardson Email

VP Clinical Operations . Rénibus Therapeutics

Current Roles

Employees:
38
Revenue:
$3.8M
About
Rénibus Therapeutics is a clinical-stage biotech company dedicated to transforming the cardiorenal disease treatment paradigm by focusing on the prevention and treatment of kidney disease. The company’s portfolio includes RBT-1 for prevention of acute kidney injury, RBT-2 for treatment of chronic kidney disease, and RBT-3 for treatment of iron deficiency anemia and platinum-based kidney toxicity.
Rénibus Therapeutics Address
181 Grand Ave
Southlake, TX
Rénibus Therapeutics Email

Past Companies

Renibus Therapeutics IncVice President Clinical Operations
Lassen TherapeuticsVice President, Clinical Operations
Precision For MedicineVice President, Project & Clinical Trial Management

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.